Oncogenic KRAS is an established driver of pancreatic cancer and several pathways that are known downstream effectors of KRAS signaling and play central roles in PDAC cancer cell growth and survival [48,49,50], were found to be marked by broad domains in domains common to all PDAC cells. Here, KRAS is linked to familial pancreatic carcinoma.